Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcimimetics: therapeutic potential in hyperparathyroidism.

Adi Cohen1, Shonni J Silverberg

  • 1Division of Endocrinology, Columbia Presbyterian Medical Center, 622 West 168th Street, PH 8WEST - 864, New York, NY 10032, USA. ac1044@columbia.edu

Current Opinion in Pharmacology
|December 17, 2002
PubMed
Summary

Maintaining calcium balance is vital for health. New calcimimetic drugs targeting the calcium-sensing receptor show promise for treating hyperparathyroidism and calcium metabolism disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same author

Postpartum timing of teriparatide initiation and BMD response in pregnancy- and lactation-associated osteoporosis: an observational study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

The Association Between Antibiotic Use and the Incidence of Third-Generation Cephalosporin-Resistance in <i>Escherichia coli</i> Bloodstream Infections: An Ecological Study.

Antibiotics (Basel, Switzerland)·2026
Same author

Pregnancy and Lactation Associated Osteoporosis of the Hip: A Systematic Review.

Calcified tissue international·2026
Same author

Bone density and remodeling after discontinuation of sequential therapy for premenopausal idiopathic osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Genetic contributors to osteoporosis in pregnancy and lactation associated osteoporosis (PLO).

Bone·2025

Area of Science:

  • Endocrinology
  • Pharmacology
  • Physiology

Background:

  • Calcium homeostasis is critical for physiological functions.
  • The extracellular calcium-sensing receptor (CaSR) is key to regulating calcium levels.
  • Disorders of calcium metabolism, like hyperparathyroidism, require effective treatments.

Purpose of the Study:

  • To highlight the role of the calcium-sensing receptor in calcium homeostasis.
  • To introduce calcimimetic agents as potential therapeutics for calcium disorders.
  • To discuss the therapeutic potential of specific compounds targeting the CaSR.

Main Methods:

  • Review of the role of the extracellular calcium-sensing receptor.
  • Identification of phenylalkylamine compounds (NPS 568, AMG 073) as CaSR agonists.

Related Experiment Videos

  • Discussion of calcimimetic drug action.

    • Main Results:

    • The calcium-sensing receptor is a validated target for modulating calcium metabolism.
    • Calcimimetic agents, such as NPS 568 and AMG 073, activate the CaSR.
    • These compounds demonstrate potential for treating parathyroid hyperfunction.

    Conclusions:

    • The extracellular calcium-sensing receptor is a significant therapeutic target.
    • Calcimimetic agents offer a promising therapeutic strategy for hyperparathyroidism.
    • Further development of CaSR-targeting drugs could address calcium metabolism disorders.